Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia.
Mulshine JL, Atkinson JC, Greer RO, Papadimitrakopoulou VA, Van Waes C, Rudy S, Martin JW, Steinberg SM, Liewehr DJ, Avis I, Linnoila RI, Hewitt S, Lippman SM, Frye R, Cavanaugh PF Jr.
Mulshine JL, et al. Among authors: hewitt s.
Clin Cancer Res. 2004 Mar 1;10(5):1565-73. doi: 10.1158/1078-0432.ccr-1020-3.
Clin Cancer Res. 2004.
PMID: 15014005
Clinical Trial.